Reabsorbable bone regenerator
OXOFIX is the result of 15 years of research in the field of ceramic biomaterials.
The research and development studies for these materials were started in the 90s at the lnstituto de Ceramica
de Galicia (Galicia’s Ceramic Institute) of the University of Santiago de Compostela (Spain). At the end of the
90s, these studies led to the creation of KERAMAT, a Spanish partner of Biotec-BTK working in the design,
manufacturing and marketing of ceramic biomaterials for clinical use.
OXOFIX materials comply with all the required quality standards for health products at international level and has on-site
Quality Insurance Systems based on the demanding ISO 9001:2000/ISO 13485:2000. It also has an EC Label to be sold in the whole European Union.
In order to ensure quality of all the OXOFIX products, the producer undertakes strict quality controls in several
production stages. KERAMAT uses 12%; of its production for quality control. In this way, OXOFIX has become a
reference in terms of quality and safety.
The products are produced and packed in conditions of total asepsis and are subjected as a last step to sterilisation
through gamma radiation.